Table 2.
Changes in CCAR2 expression levels associated with tumor progression.
| Cancer type | Expression level associated with poor prognosis | Ref |
|---|---|---|
| Breast cancer | Upregulated | 4,5 |
| Colorectal cancer | Upregulated | 14,95,96 |
| Esophageal squamous cell carcinoma | Upregulated | 111 |
| Hepatocellular carcinoma | Upregulated | 112,113 |
| Osteosarcoma | Upregulated | 92 |
| Ovarian cancer | Upregulated | 114 |
| Soft tissue sarcoma | Upregulated | 115 |
| Clear cell renal cell carcinoma | Upregulated | 116 |
| Diffuse large B cell lymphoma | Upregulated | 117 |
| Gastric cancer | Upregulated | 89,118 |
| Downregulated | 119 | |
| Pancreatic cancer | Downregulated | 120 |
| Bladder cancer | Downregulated | 121 |
| Gallbladder carcinoma | Downregulated | 122 |
| Laryngeal & hypopharyngeal carcinoma | Downregulated | 123 |